Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Myra Vision Closes $25M in Series B

CAMPBELL, CA, Myra Vision announced the closing of its $25M Series B financing led by Cormorant Asset Management.
Myra Vision, a Shifamed portfolio company, announced the closing of its $25M Series B financing. Led by Cormorant Asset Management, with significant participation from The Capital Partnership (TCP), the PA MedTech VC Fund and Shifamed angel investors, the funds will be used to further product development, scale manufacturing capabilities, and support first-in-human investigation of the company's Calibreye™ System, a novel treatment that aims to optimize reduction of intraocular pressure (IOP) for patients with moderate to advanced glaucoma.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors